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Abstract: This research investigated the effect of Sn(IV) chlorin e6 dichloride 
trisodium salt photosensitizer on the viability of HepG2 cancer cell lines in vitro. The 
effect of light on the viability of cells without the photosensitiser and the toxicity of 
the photosensitiser in the absence of light were examined in this research. No toxic 
effects with the absence of light were found and no photodamge effect on the cells 
without the presence of photosensitiser. The effect of different concentrations of the 
photosensitiser with fixed light dose of 70 J/cm2 on the viability of HepG2 cancer 
cells were performed. Then, two concentrations 25 and 30 μg/ml were investigated at 
different light doses 60-100 J/cm2. The effect of the photosensitiser on the viability of 
HepG2 at different light doses and different concentrations was found to have low 
viability over concentrations of 25 μg/ml. This could be due to that the photosensitiser 
reached a saturated status after this concentration. 
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1.  INTRODUCTION 
 
Liver cancer (hepatocellular carcinoma) or hepatoma Liver cancer is the fifth most common cancer in 
the world. Liver cancer kills almost all the patients who have it within a year. In 1990 there were 430,000 
new cases of liver cancer over the world as was estimated by the World Health Organization and a 
similar number of patient died as a result of this disease (Jianhua and Xinhong, 1998). The most cases 
were in East Asia and sub-saharan Africa (Mozambique and South Africa). 
As a promising treatment methodology photodynamic therapy PDT was used to treat such cancers. 
PDT reqires a photosensitizer and light with proper wavelength with presence of oxygen. When the 
photosensitizer is exposed to light its molecules will be excited and by decaying through the triplet state 
there will be a generation of singlet oxygen (1O2) and reactive oxygen species (ROS) which are toxic to 
cells and tissue (Ding, et al., 2004). 
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The effect of Phthalocyanine and metal-free hexadeca-carboxy phthalocyanine photosensitizer on 
HepG2 cancer cells were examined by Chi-Fung and coworkers. There results exhibited that HepG2 was 
resistant to the phototoxic effect of these two photosensitizers with concentrations up to 4μM and light 
dose of 40 J/cm2 (Chi-Fung, et al., 2004). While other studies on amphiphilic pthalocyanines found to be 
potent against HepG2 cancer cells (Lo, et al., 2004). Yow and coworkers investigate the effect of 5-ALA 
photosensitizer on HepG2 liver cancer cell lines (Yow, Wong, Huang, and Ho, 2007). Using PAD-S31 
photosensitizer in PDT with concentration of 100μg/ml, 2 hours incubation time and 20 J/cm2 of light 
dose (Date, et al., 2004). In this study investigating the effect of PDT on the viability of HepG2 
hepatoma liver cancer cell lines using Sn(IV) chlorin e6 dichloride trisodium in will be performed. 
 
2.  METHODOLOGY 
 
2.1  Chemicals 
Sn(IV) chlorin e6 dichloride Trisodium salt (Frontier Scientific, USA), was dissolved in PBS with a 
concentration 1mg/ml and kept frozen before use. 
 
2.2  Cell lines 
HepG2 human liver hepatocellular carcinoma cell lines (ATCC, USA) were used in this research. Cells 
were cultured in EMEM supplemented with 10% Fetal bovine serum (FBS) (Gibco, Malaysia). These 
cells were incubated at 37oC in a humidified atmosphere containing 95% air and 5% CO2. 
 
2.3  Cell viability assay 
MTT salt (Sigma, Malaysia) was used to determine the viability of the cell lines throughout this research. 
MTT was dissolved in PBS with concetration of 5 mg/ml directly before use. 100 μl medium containing 
20 µl MTT solution was added to each well and the microplate was incubated at 37°C, 5% CO2 for 4 
hours. At the end of incubation period the medium was discarded gently and replaced by 100 μl of 
DMSO. The plate was shaken on the microplate shaker to dissolve formazan. Absorbance was recorded 
at the 570 nm on a microplate reader with 620 nm as reference wavelength. 
 
2.4  PDT treatment 
Fresh medium containing HepG2 cells were added into 96 well plates at 2 x 104 cells per well and 
incubated in the same conditions overnight to allow attachment to the bottom. Then, the cells were 
treated with different concentrations of Sn(IV) chlorine e6 (15, 20, 25 and 30 μg/ml) and incubated for 6 
h. the first 8 well contained fresh medium alone and used as blank the second 8 wells contained cells 
without photosensitizer and were used as a controls. The cells of both PDT and control groups were 
irradiated with 635 nm light from LLC-7 high pressure spherical Xenon lamp (Lambda Scientific, North 
Adelaina, USA) using light red filter (LFord, England) cut the wavelength less than 550 nm with a light 
dosage of 70 J/cm2. After light treatment the cells were incubated for 24 h before the cell viability was 
determined by the MTT assay. 
 
2.5  Light Toxicity 
The above discribed process was followed to examine the effect of light on the viability of HepG2 cancer 
cells. Different light doses (60, 70, 80, 90, 100 J/cm2) were applied on the cells incubated in 96-well plate 
without the photosensitizer. 
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2.6  Dark Toxicity 
The cells were incubated in dark in 96-well plates with different concentrations of the Sn(IV) chlorin e6 
photosensitiser (10, 15, 20, 25 and 30 μg/ml) and was not treated with light. 
 
3.  RESULTS AND DISCUSSION 
 
The light toxicity on HepG2 cancer cells was examined at different light doses with the absence of the 
photosensitizer as shown in Figure 1. The viability of the cells was more than 95%. These data show a 
lack of phototoxicity in the irradiated cells because no differences were observed compared with the non 
irradiated cells. This indicates that the delivered light did not cause any damage to the cells. 
The dark toxicity of Sn(IV) chlorin e6 was examined and represented in Figure 2. There was a lack of 
toxicity effect of the photosensitizer in dark which is necessary for PDT. The results exhibited slightly 
differences in the viability of the cells with and without the presence of the photosensitizer in the absence 
of light. This result indicates that this Sn(IV) chlorin e6 is not toxic with absence of light at the indicated 
concentrations. 
Figure 3 shows the effect of Sn(IV) chlorin e6 on the viability of HepG2 cancer cells at different 
concentrations of the photosensitizer, fixed light dose of 70 J/cm2, and 6 hours of incubation time. There 
was a gradual decreasing of the viability with proportional to the Sn(IV) chlorin e6 concentrations. A 
small difference can be observed between 25 and 30 μg/ml. The survival rates of HepG2 cells were from 
71%±5.1% to 52%±2.5% with Sn(IV) chlorin e6 concentrations from 15 to 30μg/ml. There was steep 
decreasing in the viability of the cells from 15 to 25 μg/ml while no significat difference was observed 
from 25 to 30 μg/ml. So these result suggested that HepG2 cellular uptake of Sn(IV) chlorin e6 increased 
with the incubation of the photosensitizer at concentrations from 15 to 25 μg/ml and then became 
saturated at higher concentrations. Accordingly, no significant increasing in the generation of singlet 
oxygen or ROS which cause the damage the cells. This result is important in clinical PDT in order to 
optimize the dose of Sn(IV) chlorin e6. 
Figure 4 represents the viability of HepG2 cancer cell lines as a function of light dose at two 
concentrations 25 and 30 μg/ml with 6 hours incubation time. There was a gradual decreasing of the 
viability by the increasing of light dose but this decreasing of viability is not steep. The lowest viability 
was about 52% at light dose of 100 J/cm2 and 30 μg/ml concentration. Comparing the effect of two 
concentrations it can be seen from Fig. 4 that there is no significant difference between the effect of the 
two concentrations. This could support our suggestion on the basis of saturation. 
Enough energy is necessary to complete the excitation process of the photosensitizer molecules. If 
there is not enough energy the number of excited molecules will be reduced which results in a lack of the 
biological effects. This illustrates that the survival rate will decrease as the light dose increases. This 
increasing could be explained on the basis of that the increase of light dose increases the energy which 
resulted in more absorption of photons by molecules ,subsequently more generation of singlet oxygen 
and ROS then more cell damage. The results are with good agreement with this suggession. 
The effect of Sn(IV) chlorin e6 on the viability of HepG2 was less than effect of other 
photosensitizers such as 5-ALA and PAD-S31 which reached 80% of phototoxicity, while this 
photosensitizer did not exceed 50% at the indicated concentrations and doses. This could be due to the 
less phosphorescence which are the most important in PDT compared with fluorescence for the excited 
molecules. Also since the photobleaching of the photosensitizer reduces its absorption of light (Ishii, et 
al., 2008), it could be an important factor in the lack of phototoxicity of Sn(IV) chlorin e6. 
  
4.  CONCLUSION 
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In conclusion, Sn(IV) chlorin was found to be non toxic in dark and cause damage to HepG2 liver cancer 
cells. The PDT damage to HepG2 cells increased with increasing of the concentration of the 
photosensitiser and then plateaued at concentrations more than 25 μg/ml. The cell killing was 
proportioanl to light doses of the irradaited light. More experiments may be performed in future to 
investigate more characterizations of this photosensitizer and its effects in PDT on ather cancer cell 
lines. 
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Fig. 1: The viability of HepG2 liver cancer cell lines after illuminating by different doses of light 
with the absence of the photosensitizer 
 
 
Fig. 2: The viability of HepG2 liver cancer cell lines after 12 hours of incubation time without 
exposing to light 
 
 
Fig. 3: The viability of HepG2 cancer cell lines in different concentrations of the photosnesitizer 
with fixed light dose of 70 J/cm2 
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Fig. 4: The viability of HepG2 cancer cells with two photosensitier concentrations and different 
light doses 
 
 
